Neoadjuvant versus perioperative immunotherapy in resectable NSCLC: A PD-L1-stratified Bayesian network meta-analysis
{{output}}
Background: Neoadjuvant immunochemotherapy (NIC) and perioperative immunochemotherapy (PIC) improve outcomes in resectable non-small cell lung cancer (NSCLC), but their relative effects across programmed death-ligand 1 (PD-L1) su... ...
